Literature DB >> 9648877

Ornithine decarboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease.

L D Morrison1, X C Cao, S J Kish.   

Abstract

Although experimental animal data have implicated ornithine decarboxylase, a key regulatory enzyme of polyamine biosynthesis, in brain development and function, little information is available on this enzyme in normal or abnormal human brain. We examined the influence, in autopsied human brain, of postnatal development and aging, regional distribution, and Alzheimer's disease on the activity of ornithine decarboxylase. Consistent with animal data, human brain ornithine decarboxylase activity was highest in the perinatal period, declining sharply (by approximately 60%) during the first year of life to values that remained generally unchanged up to senescence. In adult brain, a moderately heterogeneous regional distribution of enzyme activity was observed, with high levels in the thalamus and occipital cortex and low levels in cerebellar cortex and putamen. In the Alzheimer's disease group, mean ornithine decarboxylase activity was significantly increased in the temporal cortex (+76%), reduced in occipital cortex (-70%), and unchanged in hippocampus and putamen. In contrast, brain enzyme activity was normal in patients with the neurodegenerative disorder spinocerebellar ataxia type I. Our demonstration of ornithine decarboxylase activity in neonatal and adult human brain suggests roles for ornithine decarboxylase in both developing and mature brain function, and we provide further evidence for the involvement of abnormal polyamine system activity in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648877     DOI: 10.1046/j.1471-4159.1998.71010288.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

Review 1.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

2.  Spermine binding to Parkinson's protein alpha-synuclein and its disease-related A30P and A53T mutants.

Authors:  Megan Grabenauer; Summer L Bernstein; Jennifer C Lee; Thomas Wyttenbach; Nicholas F Dupuis; Harry B Gray; Jay R Winkler; Michael T Bowers
Journal:  J Phys Chem B       Date:  2008-08-09       Impact factor: 2.991

3.  Alterations in neuronal metabolism contribute to the pathogenesis of prion disease.

Authors:  Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert
Journal:  Cell Death Differ       Date:  2018-06-18       Impact factor: 15.828

4.  Serum amino acid profiles in patients with mild cognitive impairment and in patients with mild dementia or moderate dementia.

Authors:  Edyta Socha; Piotr Kośliński; Marcin Koba; Katarzyna Mądra-Gackowska; Marcin Gackowski; Kornelia Kędziora-Kornatowska; Emilia Daghir-Wojtkowiak
Journal:  Amino Acids       Date:  2021-01-06       Impact factor: 3.520

5.  Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease.

Authors:  Kuo-Hsuan Chang; Mei-Ling Cheng; Hsiang-Yu Tang; Cheng-Yu Huang; Yih-Ru Wu; Chiung-Mei Chen
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

6.  LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent.

Authors:  Shweta S Puntambekar; Deirdre S Davis; Leo Hawel; Janelle Crane; Craig V Byus; Monica J Carson
Journal:  Brain Behav Immun       Date:  2011-01-13       Impact factor: 7.217

7.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

8.  NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation.

Authors:  Claudio O Fernández; Wolfgang Hoyer; Markus Zweckstetter; Elizabeth A Jares-Erijman; Vinod Subramaniam; Christian Griesinger; Thomas M Jovin
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

9.  Critical factors determining dimerization of human antizyme inhibitor.

Authors:  Kuo-Liang Su; Ya-Fan Liao; Hui-Chih Hung; Guang-Yaw Liu
Journal:  J Biol Chem       Date:  2009-07-27       Impact factor: 5.157

Review 10.  Implication of the polyamine system in mental disorders.

Authors:  Laura M Fiori; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.